Balance Sheet

Assets

-36%

-34%

10Y

Currency: KRW

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2024
Assets
Cash & Cash Equivalents	2 051	1 890	5 749	1 368	3 612	7 731	4 735	7 774	4 437	16 577	16 902	6 537	27 827	24 768	23 691	21 678	34 817	51 885	47 231	30 955	29 964	42 933
Cash	0	0	0	0	0	0	0	0	0	0	3	3	4	4	3	3	2	9	7	0	0	7
Cash Equivalents	2 051	1 890	5 749	1 368	3 612	7 731	4 735	7 774	4 437	16 577	16 899	6 534	27 823	24 764	23 688	21 675	34 815	51 876	47 224	30 954	29 964	42 926
Short-Term Investments	5 658	4 851	2 626	4 769	14 591	11 342	30 586	12 221	11 360	12 029	6 273	1 326	809	1 366	1 727	8 968	123 777	96 717	91 926	91 545	51 954	10 509
Total Receivables	83	154	129	104	444	355	1 517	1 511	1 599	1 360	1 943	4 110	3 058	9 311	6 861	3 066	7 392	48 172	13 780	13 064	9 950	12 203
Accounts Receivables	41	69	49	59	316	118	1 092	968	1 252	1 038	1 810	3 558	2 599	8 063	5 199	2 817	7 135	44 926	9 958	10 581	8 031	9 510
Other Receivables	42	85	80	45	128	237	425	543	347	322	133	552	459	1 248	1 662	249	257	3 246	3 822	2 482	1 919	2 693
Inventory	0	0	0	0	0	0	0	43	0	0	0	0	107	1 270	3 994	517	449	40 207	10 010	8 578	5 677	9 181
Other Current Assets	149	133	134	98	166	960	918	1 382	746	462	422	324	330	1 113	3 420	264	323	1 230	17 857	824	1 309	977
Total Current Assets	7 942	7 028	8 638	6 339	18 813	20 389	37 756	22 845	18 142	30 427	25 539	12 297	32 130	37 828	39 694	34 493	166 758	238 210	180 805	144 965	98 854	75 802
PP&E Net	696	637	857	706	1 662	2 936	4 190	4 530	6 949	13 004	11 876	13 864	13 143	24 043	24 477	23 454	22 883	76 067	43 143	86 371	100 174	133 246
PP&E Gross	696	637	857	706	1 662	2 936	4 190	4 530	6 949	13 004	11 876	13 864	13 143	24 043	24 477	23 454	0	76 067	43 143	86 371	100 174	133 246
Accumulated Depreciation	554	934	1 381	1 982	2 618	3 268	3 817	4 308	4 612	9 800	10 550	10 342	11 242	11 430	11 787	11 962	0	22 335	17 382	15 326	17 039	18 179
Intangible Assets	1 085	1 304	632	621	3 906	11 952	17 103	21 714	4 321	4 289	3 809	3 361	2 875	2 410	2 050	1 695	1 339	11 790	9 482	8 120	6 405	5 474
Goodwill	0	0	0	0	0	0	0	0	0	7 702	5 817	3 629	2 332	4 993	4 986	2 332	0	5 733	2 026	2 026	2 026	3 235
Note Receivable	251	390	596	451	415	350	170	145	158	148	58	58	23	0	0	0	0	2	31	326	320	959
Long-Term Investments	9	15	1 034	1 563	7 273	3 035	3 150	3 179	677	7 319	7 239	55 508	55 511	57 560	56 243	57 471	65 362	44 607	81 396	89 833	102 065	37 576
Other Long-Term Assets	39	41	219	193	241	383	881	906	466	74	326	52	38	451	1 217	19	578	2 781	77	1 287	12 769	4 173
Other Assets	0	0	0	0	0	0	0	0	0	7 702	5 817	3 629	2 332	4 993	4 986	2 332	0	5 733	2 026	2 026	2 026	3 235
Total Assets	10 021 N/A	9 415 -6%	11 975 +27%	9 873 -18%	32 310 +227%	39 045 +21%	63 250 +62%	53 320 -16%	30 713 -42%	62 964 +105%	54 666 -13%	88 769 +62%	106 052 +19%	127 285 +20%	128 666 +1%	119 465 -7%	256 920 +115%	379 189 +48%	316 960 -16%	332 927 +5%	322 613 -3%	260 465 -19%
Liabilities
Accounts Payable	0	0	0	0	0	0	0	0	0	0	0	57	1 596	4 005	2 058	739	346	7 979	3 464	2 111	1 854	4 138
Accrued Liabilities	68	41	20	31	4	2	1	84	103	258	291	206	185	435	605	116	139	4 359	4 824	4 885	3 225	1 135
Short-Term Debt	167	125	459	582	465	465	197	0	592	8 579	7 945	2 499	2 300	24 074	13 520	5 200	1 000	41 909	37 680	38 045	44 145	6 900
Current Portion of Long-Term Debt	0	0	999	0	0	0	15 166	0	0	0	13 038	0	18 200	1 688	18 481	6 432	6 245	37 153	9 474	12 279	5 546	44 151
Other Current Liabilities	1 246	1 507	1 402	1 444	1 051	2 091	2 297	3 031	1 481	3 136	8 404	3 357	9 498	8 149	5 572	4 480	2 528	43 198	15 921	9 193	26 068	23 611
Total Current Liabilities	1 480	1 673	2 880	2 057	1 520	2 558	17 661	3 116	2 177	11 972	29 679	6 120	31 779	38 351	40 236	16 967	10 258	134 598	71 363	66 513	80 837	79 936
Long-Term Debt	2 489	2 250	1 792	2 210	662	1 234	1 037	2 189	4 146	12 008	500	32 047	13 512	9 459	1 863	7 800	31 286	12 537	14 763	24 399	20 508	42 396
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	0	1 818	1 818	1 859	2 126	2 126	2 356	3 535	3 464	12 504	12 392	14 818
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	1 698	107	0	0	76 168	5 658	6 789	9 822	23 602
Other Liabilities	154	237	305	356	487	573	1 990	1 915	2 373	8 613	2 113	12 622	3 916	3 976	1 176	985	28 553	3 303	6 955	14 884	10 779	1 195
Total Liabilities	4 124 N/A	4 160 +1%	4 977 +20%	4 622 -7%	2 669 -42%	4 365 +64%	20 688 +374%	7 219 -65%	8 697 +20%	32 593 +275%	32 292 -1%	52 606 +63%	51 024 -3%	55 344 +8%	45 508 -18%	27 878 -39%	72 453 +160%	230 141 +218%	102 203 -56%	125 089 +22%	134 337 +7%	161 947 +21%
Equity
Common Stock	1 681	1 681	1 999	2 022	2 818	4 435	5 140	5 160	5 160	8 592	8 810	9 673	11 298	12 258	12 941	13 568	20 889	21 064	23 082	34 623	35 373	38 447
Retained Earnings	511	131	1 888	3 829	6 518	9 616	17 033	13 678	37 788	46 646	58 595	69 933	81 826	87 069	88 925	97 405	90 260	128 017	42 380	26 561	3 083	13 531
Additional Paid In Capital	3 706	3 706	6 844	6 911	32 840	39 710	54 822	55 092	54 144	69 458	72 451	88 789	117 811	136 618	150 469	167 114	245 645	246 593	125 939	113 912	118 937	53 714
Unrealized Security Profit/Loss	0	0	44	147	500	151	367	474	666	1 134	365	7 567	7 667	8 701	8 144	8 227	8 191	9 939	9 853	32 215	32 209	31 980
Treasury Stock	0	0	0	0	0	0	0	0	0	13	13	13	13	13	13	13	121	121	121	12 879	14 488	0
Other Equity	0	0	0	0	0	0	0	0	1 166	115	86	81	90	1 444	544	96	122	410	13 625	13 406	13 161	12 092
Total Equity	5 897 N/A	5 255 -11%	6 998 +33%	5 251 -25%	29 641 +464%	34 680 +17%	42 562 +23%	46 100 +8%	22 016 -52%	30 371 +38%	22 374 -26%	36 164 +62%	55 028 +52%	71 941 +31%	83 158 +16%	91 587 +10%	184 467 +101%	149 049 -19%	214 757 +44%	207 838 -3%	188 276 -9%	98 518 -48%
Total Liabilities & Equity	10 021 N/A	9 415 -6%	11 975 +27%	9 873 -18%	32 310 +227%	39 045 +21%	63 250 +62%	53 320 -16%	30 713 -42%	62 964 +105%	54 666 -13%	88 769 +62%	106 052 +19%	127 285 +20%	128 666 +1%	119 465 -7%	256 920 +115%	379 189 +48%	316 960 -16%	332 927 +5%	322 613 -3%	260 465 -19%
Shares Outstanding
Common Shares Outstanding	13	13	15	15	21	25	29	29	29	34	35	39	45	49	52	54	61	61	69	68	69	77
Preferred Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	4	15

Income Statement Balance Sheet Cash Flow Statement

CrystalGenomics Inc
KOSDAQ:083790

Balance Sheet

Balance Sheet Decomposition
CrystalGenomics Inc

Balance Sheet
CrystalGenomics Inc

See Also

Company

Help

Tools

Stocks

CrystalGenomics Inc KOSDAQ:083790

Balance Sheet

Balance Sheet Decomposition CrystalGenomics Inc

Balance Sheet CrystalGenomics Inc

See Also

Company

Help

Tools

Stocks

CrystalGenomics Inc
KOSDAQ:083790

Balance Sheet Decomposition
CrystalGenomics Inc

Balance Sheet
CrystalGenomics Inc